JP2004534788A5 - - Google Patents

Download PDF

Info

Publication number
JP2004534788A5
JP2004534788A5 JP2003502981A JP2003502981A JP2004534788A5 JP 2004534788 A5 JP2004534788 A5 JP 2004534788A5 JP 2003502981 A JP2003502981 A JP 2003502981A JP 2003502981 A JP2003502981 A JP 2003502981A JP 2004534788 A5 JP2004534788 A5 JP 2004534788A5
Authority
JP
Japan
Prior art keywords
combination
optionally substituted
macrocyclic lactone
receptor
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003502981A
Other languages
English (en)
Japanese (ja)
Other versions
JP4476623B2 (ja
JP2004534788A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/006278 external-priority patent/WO2002100148A2/en
Publication of JP2004534788A publication Critical patent/JP2004534788A/ja
Publication of JP2004534788A5 publication Critical patent/JP2004534788A5/ja
Application granted granted Critical
Publication of JP4476623B2 publication Critical patent/JP4476623B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003502981A 2001-06-08 2002-06-07 インスリン産生細胞移植片拒絶の処置または予防 Expired - Fee Related JP4476623B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29706901P 2001-06-08 2001-06-08
PCT/EP2002/006278 WO2002100148A2 (en) 2001-06-08 2002-06-07 Treatment or prophylaxis of insulin-producing cell graft rejection

Publications (3)

Publication Number Publication Date
JP2004534788A JP2004534788A (ja) 2004-11-18
JP2004534788A5 true JP2004534788A5 (https=) 2005-12-22
JP4476623B2 JP4476623B2 (ja) 2010-06-09

Family

ID=23144725

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003502981A Expired - Fee Related JP4476623B2 (ja) 2001-06-08 2002-06-07 インスリン産生細胞移植片拒絶の処置または予防

Country Status (18)

Country Link
US (5) US20030003099A1 (https=)
EP (1) EP1429845B1 (https=)
JP (1) JP4476623B2 (https=)
CN (1) CN1524002A (https=)
AT (1) ATE424893T1 (https=)
AU (1) AU2002320828B2 (https=)
BR (1) BR0209319A (https=)
CA (1) CA2445605A1 (https=)
DE (1) DE60231522D1 (https=)
ES (1) ES2322442T3 (https=)
IL (1) IL158384A0 (https=)
NO (1) NO20035434D0 (https=)
NZ (1) NZ529044A (https=)
PL (1) PL364359A1 (https=)
PT (1) PT1429845E (https=)
RU (1) RU2003136730A (https=)
WO (1) WO2002100148A2 (https=)
ZA (1) ZA200307893B (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2267993T3 (es) * 2001-02-22 2007-03-16 Novartis Ag Uso de agentes de migracion acelerada de linfocitos para la fabricacion de un medicamento para el tratamiento de la funcion retardada del injerto.
ES2528362T3 (es) * 2004-05-14 2015-02-09 Alexion Pharmaceuticals, Inc. Prolongación de la supervivencia de un aloinjerto por inhibición de la actividad del complemento
CN101014329B (zh) * 2004-07-16 2010-09-08 杏林制药株式会社 用于对器官或组织的移植的排异反应或骨髓移植的移植物抗宿主反应预防或治疗的药物组合物
KR20140095109A (ko) * 2004-11-29 2014-07-31 노파르티스 아게 Ｓ１ｐ 수용체 효능제의 투여 용법
US20080206240A1 (en) * 2005-02-08 2008-08-28 Shreeram Aradhye Antilymphocyte Antibody Induction
US20090191218A1 (en) 2005-05-11 2009-07-30 Fengchun Li DNA Vaccines And Methods For The Prevention Of Transplantation Rejection
DE602006015373D1 (de) * 2005-05-11 2010-08-19 Univ Loma Linda Zusammensetzungen und Verfahren zur Prävention und Behandlung von immunvermittelten Entzündungskrankheiten
KR101346527B1 (ko) * 2005-12-15 2013-12-31 미쓰비시 타나베 파마 코퍼레이션 아민 화합물 및 그 의약 용도
RS53864B1 (sr) * 2006-03-02 2015-08-31 Alexion Pharmaceuticals, Inc. Produžavanje preživljavanja alografta inhibiranjem aktivnosti komplementa
EP2069375B1 (en) * 2006-09-28 2012-03-28 Loma Linda University Apoptotic cell-mediated transfection of mammalian cells with interfering RNA
WO2009099174A1 (ja) 2008-02-07 2009-08-13 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤
EP3332801B1 (en) * 2008-03-12 2023-09-13 Loma Linda University Dna vaccines and methods for the prevention of transplantation rejection
HUE033168T2 (en) 2008-03-17 2017-11-28 Actelion Pharmaceuticals Ltd Dosage regimen for selective SIP1 receptor agonist
CA2743232C (en) * 2008-11-11 2015-12-29 Novartis Ag Crystalline forms of fingolimod hcl
MX2011004924A (es) * 2008-11-11 2011-05-30 Novartis Ag Sales de fingolimod.
EP2455876A3 (en) * 2009-06-30 2013-01-30 Lifescan Scotland Limited System and method for diabetes management
JP5654587B2 (ja) * 2009-06-30 2015-01-14 ライフスキャン・インコーポレイテッドＬｉｆｅｓｃａｎ，Ｉｎｃ． 基礎インスリン療法を算出する分析物試験方法及び装置
ES2631610T3 (es) * 2009-09-29 2017-09-01 Lifescan Scotland Limited Dispositivo y método de ensayo de analito para la gestión de la diabetes
WO2011106029A1 (en) * 2010-02-25 2011-09-01 Lifescan Scotland Limited Analyte testing method and system with high and low blood glucose trends notification
US11680273B2 (en) 2011-09-23 2023-06-20 Loma Linda University Treatment of autoimmune diseases
US10813987B2 (en) 2011-09-23 2020-10-27 Loma Linda University Method for inducing a tolerogenic immune response
CN114306643A (zh) * 2021-11-30 2022-04-12 中国科学院昆明动物研究所 一种恒河猴免疫抑制模型的构建方法及在car-t细胞植活上的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604229A (en) * 1992-10-21 1997-02-18 Yoshitomi Pharmaceutical Industries, Ltd. 2-amino-1,3-propanediol compound and immunosuppressant
US5679546A (en) * 1993-09-24 1997-10-21 Cytomed, Inc. Chimeric proteins which block complement activation
WO1995023512A1 (en) * 1994-03-03 1995-09-08 Alexion Pharmaceuticals, Inc. Terminal complement inhibitor fusion genes and proteins
GB9624038D0 (en) * 1996-11-19 1997-01-08 Sandoz Ltd Organic compounds
JPH1180026A (ja) * 1997-09-02 1999-03-23 Yoshitomi Pharmaceut Ind Ltd 新規免疫抑制剤、その使用方法およびその同定方法
ES2267993T3 (es) * 2001-02-22 2007-03-16 Novartis Ag Uso de agentes de migracion acelerada de linfocitos para la fabricacion de un medicamento para el tratamiento de la funcion retardada del injerto.

Similar Documents

Publication Publication Date Title
JP2004534788A5 (https=)
RU2009143333A (ru) Производные аминодигидротиазина, замещенные циклической группой
JP2004516314A5 (https=)
JP2006514021A5 (https=)
JP2005506352A5 (https=)
RU2010107284A (ru) Производные нафтиридина в качестве модуляторов калиевых каналов
JP2008514732A5 (https=)
GEP20094723B (en) Tetraazabenzo [e] azulene derivatives and analogs thereof
RU2013107007A (ru) Бифункциональные соединения, являющиеся ингибиторами rho-киназы, композиция и применение
JP2006501181A5 (https=)
KR20180132939A (ko) 암 치료를 위한 조합 요법
JP2008510691A5 (https=)
JP2008525416A5 (https=)
JP2013532652A5 (https=)
JP2005533775A5 (https=)
JP2004531544A5 (https=)
KR950704330A (ko) 면역억제제로서의 라파마이신 카보네이트 에스테르(Rapamycin carbonate esters as immunosuppressant agents)
RU2003136730A (ru) Лечение или профилактика отторжения инсулин-продуцирующего клеточного трансплантата
RU2006137794A (ru) Химические составы, композиции и способы их использования
CN1277553A (zh) 血管生成促进剂和血管生成增效剂
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2009511508A5 (https=)
JP2012519691A5 (https=)
RU99112577A (ru) Новое применение 1,3-пропандиольных производных
ATE528306T1 (de) Benzoxazepin-verbindungen, ihre herstellung und verwendung